{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:31:34Z","timestamp":1776753094580,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Severe gait disturbances in idiopathic Parkinson's disease (PD) are observed in up to 80% of all patients in advanced disease stages with important impact on quality of life. There is an unmet need for further symptomatic therapeutic strategies, particularly as gait disturbances generally respond unfavourably to dopaminergic medication and conventional deep brain stimulation of the subthalamic nucleus in advanced disease stages. Recent pathophysiological research pointed to nigro-pontine networks entrained to locomotor integration. Stimulation of the pedunculopontine nucleus is currently under investigation, however, hitherto remains controversial. The substantia nigra pars reticulata (SNr) - entrained into integrative locomotor networks - is pathologically overactive in PD. High-frequent stimulation of the substantia nigra pars reticulata preferentially modulated axial symptoms and therefore is suggested as a novel therapeutic candidate target for neuromodulation of refractory gait disturbances in PD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>12 patients with idiopathic Parkinson's disease and refractory gait disturbances under best individual subthalamic nucleus stimulation and dopaminergic medication will be enroled into this double-blind 2 \u00d7 2 cross-over clinical trial. The treatment consists of two different stimulation settings using <jats:italic>(i)<\/jats:italic> conventional stimulation of the subthalamic nucleus [STNmono] and <jats:italic>(ii)<\/jats:italic> combined stimulation of distant electrode contacts located in the subthalamic nucleus and caudal border zone of STN and substantia nigra pars reticulata [STN+SNr]. The primary outcome measure is the change of the cumulative 'axial score' (UPDRS II items '13-15' and UPRDS III items '27-31') at three weeks of constant stimulation in either condition. Secondary outcome measures include specific scores on freezing of gait, balance function, quality of life, non-motor symptoms, and neuropsychiatric symptoms. The aim of the present trial is to investigate the efficacy and safety of a three week constant combined stimulation on [STN+SNr] compared to [STNmono]. The results will clarify, whether stimulation on nigral contacts additional to subthalamic stimulation will improve therapeutic response of otherwise refractory gait disturbances in PD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>The trial was registered with the clinical trials register of <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\" ext-link-type=\"uri\">http:\/\/www.clinicaltrials.gov<\/jats:ext-link> (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01355835\" ext-link-type=\"uri\">NCT01355835<\/jats:ext-link>)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-12-222","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T20:02:40Z","timestamp":1320177760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Combined STN\/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Daniel","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"W\u00e4chter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Meisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Gharabaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Plewnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Breit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rejko","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"issue":"Suppl 2","key":"754_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/mds.21914","volume":"23","author":"N Giladi","year":"2008","unstructured":"Giladi N: Medical treatment of freezing of gait. Mov Disord. 2008, 23 (Suppl 2): 482-488.","journal-title":"Mov Disord"},{"key":"754_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s007020170096","volume":"108","author":"N Giladi","year":"2001","unstructured":"Giladi N, Treves TA, Simon ES, Shabtai H, Orlov Y, Kandinov B, Paleacu D, Korczyn AD: Freezing of gait in patients with advanced Parkinson's disease. J Neural Transm. 2001, 108: 53-61. 10.1007\/s007020170096.","journal-title":"J Neural Transm"},{"key":"754_CR3","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21659","volume":"22","author":"O Moore","year":"2007","unstructured":"Moore O, Peretz C, Giladi N: Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait. Mov Disord. 2007, 22: 2192-2195. 10.1002\/mds.21659.","journal-title":"Mov Disord"},{"key":"754_CR4","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","volume":"70","author":"D Muslimovic","year":"2008","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ: Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008, 70: 2241-2247. 10.1212\/01.wnl.0000313835.33830.80.","journal-title":"Neurology"},{"key":"754_CR5","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/mds.21667","volume":"23","author":"S Rahman","year":"2008","unstructured":"Rahman S, Griffin HJ, Quinn NP, Jahanshahi M: Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord. 2008, 23: 1428-1434. 10.1002\/mds.21667.","journal-title":"Mov Disord"},{"key":"754_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"9","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P: A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006, 9: 896-908.","journal-title":"N Engl J Med"},{"issue":"Suppl 14","key":"754_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/mds.20962","volume":"21","author":"G Kleiner-Fisman","year":"2006","unstructured":"Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G: Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006, 21 (Suppl 14): 290-304.","journal-title":"Mov Disord"},{"key":"754_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2008.929","volume":"1","author":"FM Weaver","year":"2009","unstructured":"Weaver FM, Follet K, Stern M: Bilateral deep brain stimulation vs. best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 2009, 1: 63-73.","journal-title":"Jama"},{"key":"754_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"349","author":"P Krack","year":"2003","unstructured":"Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003, 349: 1925-1934. 10.1056\/NEJMoa035275.","journal-title":"N Engl J Med"},{"key":"754_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1212\/01.wnl.0000303972.16279.46","volume":"71","author":"C Moreau","year":"2008","unstructured":"Moreau C, Defebvre L, Destee A, Bleuse S, Clement F, Blatt JL, Krystkowiak P, Devos D: STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology. 2008, 71: 80-84. 10.1212\/01.wnl.0000303972.16279.46.","journal-title":"Neurology"},{"key":"754_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/brain\/awp229","volume":"133","author":"MU Ferraye","year":"2010","unstructured":"Ferraye MU, Debu B, Fraix V, Goetz L, Ardouin C, Yelnik J, Henry-Lagrange C, Seigneuret E, Piallat B, Krack P, Le Bas JF, Benabid AL, Chabardes S, Pollak P: Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain. 2010, 133: 205-214. 10.1093\/brain\/awp229.","journal-title":"Brain"},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/brain\/awp261","volume":"133","author":"E Moro","year":"2010","unstructured":"Moro E, Hamani C, Poon YY, Al-Khairallah T, Dostrovsky JO, Hutchison WD, Lozano AM: Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain. 2010, 133: 215-224. 10.1093\/brain\/awp261.","journal-title":"Brain"},{"key":"754_CR13","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/brain\/awl346","volume":"130","author":"A Stefani","year":"2007","unstructured":"Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P: Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain. 2007, 130: 1596-1607. 10.1093\/brain\/awl346.","journal-title":"Brain"},{"key":"754_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/02688699845078","volume":"12","author":"TZ Aziz","year":"1998","unstructured":"Aziz TZ, Davies L, Stein J, France S: The role of descending basal ganglia connections to the brain stem in parkinsonian akinesia. Br J Neurosurg. 1998, 12: 245-249. 10.1080\/02688699845078.","journal-title":"Br J Neurosurg"},{"key":"754_CR15","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/j.1460-9568.2006.05106.x","volume":"24","author":"S Breit","year":"2006","unstructured":"Breit S, Lessmann L, Unterbrink D, Popa RC, Gasser T, Schulz JB: Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model. Eur J Neurosci. 2006, 24: 2275-2282. 10.1111\/j.1460-9568.2006.05106.x.","journal-title":"Eur J Neurosci"},{"key":"754_CR16","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1097\/00001756-200412030-00012","volume":"15","author":"N Jenkinson","year":"2004","unstructured":"Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ: Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport. 2004, 15: 2621-2624. 10.1097\/00001756-200412030-00012.","journal-title":"Neuroreport"},{"key":"754_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/brain\/awn294","volume":"132","author":"N Chastan","year":"2009","unstructured":"Chastan N, Westby GW, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML: Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease. Brain. 2009, 132: 172-184.","journal-title":"Brain"},{"key":"754_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00415-011-5906-3","volume":"258","author":"D Weiss","year":"2011","unstructured":"Weiss D, Breit S, W\u00e4chter T, Plewnia C, Gharabaghi A, Kr\u00fcger R: Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson's disease. J Neurol. 2011, 258: 1183-1185. 10.1007\/s00415-011-5906-3.","journal-title":"J Neurol"},{"key":"754_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/mds.21387","volume":"22","author":"J Herzog","year":"2007","unstructured":"Herzog J, Pinsker M, Wasner M, Steigerwald F, Wailke S, Deuschl G, Volkmann J: Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord. 2007, 22: 679-684. 10.1002\/mds.21387.","journal-title":"Mov Disord"},{"key":"754_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"A Hughes","year":"1992","unstructured":"Hughes A, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55: 181-184. 10.1136\/jnnp.55.3.181.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"754_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/mds.23583","volume":"5","author":"A Fasano","year":"2011","unstructured":"Fasano A, Herzog J, Seifert E, Stolze H, Falk D, Reese R, Volkmann J, Deuschl G: Modulation of gait coordination by subthalamic stimulation improves freezing of gait. Mov Disord. 2011, 5: 844-851.","journal-title":"Mov Disord"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-12-222\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:20:35Z","timestamp":1630516835000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-12-222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-12-222","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]},"assertion":[{"value":"26 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"222"}}